Celgene Corp (NASDAQ:CELG)

90.88
Delayed Data
As of Aug 20
 +0.51 / +0.56%
Today’s Change
74.13
Today|||52-Week Range
147.17
-12.92%
Year-to-Date

Today’s Trading

Previous close90.37
Today’s open90.42
Day’s range89.83 - 91.28
Volume4,694,106
Average volume (3 months)6,303,663
Market cap$62.8B
Data as of 4:00pm ET, 08/20/2018

Growth & Valuation

Earnings growth (last year)+46.18%
Earnings growth (this year)+17.47%
Earnings growth (next 5 years)+17.90%
Revenue growth (last year)+17.40%
P/E ratio24.9
Price/Sales6.58
Price/Book9.79

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.08+0.19%
BMYBristol-Myers Squibb-0.57-0.94%
NVONovo Nordisk+0.75+1.58%
ABBVAbbVie-1.18-1.19%
Data as of 4:02pm ET, 08/20/2018

Financials

Next reporting dateOctober 25, 2018
EPS forecast (this quarter)$2.22
Annual revenue (last year)$12.8B
Annual profit (last year)$2.9B
Net profit margin22.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
Chief Financial Officer &
Executive Vice President
David V. Elkins
Corporate headquarters
Summit, New Jersey

Forecasts